← all works
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet Diabetes & Endocrinology
- Topic
- Diabetes Treatment and Management
- Field
- Medicine
- Canadian institutions
- Hamilton Health SciencesMcMaster UniversityPopulation Health Research Institute
- Funders
- British Heart Foundation
- Keywords
- MedicineType 2 diabetesMeta-analysisGlucagon-like peptide 1 receptorDiabetes mellitusMEDLINEInternal medicineIntensive care medicineBioinformaticsPharmacologyReceptorEndocrinologyAgonist
- Has abstract in OpenAlex
- no